December 22, 2022
Lipella Pharmaceuticals Inc, a Delaware corporation, announced today the closing of its initial public offering and the sale of 1,217,391 shares of common stock, at a purchase price of $5.75 per share, for aggregate gross proceeds of approximately $6,999,998.25.
Spartan Capital Securities, LLC acted as the representative of the underwriters of the offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to Spartan Capital Securities, LLC.
Hunter Taubman Fischer & Li LLC is a boutique law firm specializing in corporate, commercial and securities transactions, cross-border financing, immigration and taxation. Our team of lawyers works together so our clients can benefit from astute business experience and sophisticated legal solutions.